Device Orthodontics

Titanium Orthos

Payments companies reported to CMS as associated with Titanium Orthos. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$5,915associated payments (2023-2025)
114clinicians with associated payments
2companies reporting

By year

2023 $1,749
2024 $1,676
2025 $2,490

Payments reported as associated with Titanium Orthos, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Orthodontics and Dentofacial Orthopedics $4,825
General Practice (Dentist) $492
Dentist $270
Oral and Maxillofacial Surgery $140

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Titanium Orthos

These are the largest totals companies reported as associated with Titanium Orthos. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
Mark Coreil Ville Platte, LA Orthodontics and Dentofacial Orthopedics $255.33
Christine Brinley Maryville, IL Orthodontics and Dentofacial Orthopedics $217.34
Matthew Ames Norfolk, NE Orthodontics and Dentofacial Orthopedics $210.15
Daniel Peterson Moorhead, MN Orthodontics and Dentofacial Orthopedics $210.15
Christian Davillier Pensacola, FL Orthodontics and Dentofacial Orthopedics $198.69
Jaclyn Kostelac Saint Louis, MO $188.13
Stephen Chen Houston, TX Orthodontics and Dentofacial Orthopedics $167.75
Marybeth Marcincin Bethlehem, PA Orthodontics and Dentofacial Orthopedics $131.31
Justin Silvestre Philadelphia, PA Orthodontics and Dentofacial Orthopedics $130.46
David Lange Cincinnati, OH Orthodontics and Dentofacial Orthopedics $128.17

Prescribed Titanium Orthos?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.